The business of precision medical imaging is poised to take off in the next few years, according to a new analysis by Frost & Sullivan.
The market research firm’s report, “Growth Opportunities in Precision Medical Imaging, Forecast to 2022,” said new technologies and processes in diagnostic and therapeutic imaging could spur the market to grow from $120 million in 2017 to more than $8 billion by 2027. Technology advances such as clinical decision support software, sensors, 3D printing, and precision analytics capabilities like deep learning and artificial intelligence (AI) will be applied to medical imaging.
A few firms have pulled ahead, and the rest won’t be far behind, the firm predicted.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.